OLR1 and stroke disorder: Serum levels of sLOX-1 did not significantly differ between the sexes or in those with hypertension, hyperlipidemia, diabetes mellitus, a significant family history of ischemic heart disease, previous TIA or stroke, inflammatory arthritis, atrial fibrillation, or in those taking any of the cardiac medications assessed in this study (Table 5).